• FINANCIAL MODELLING AND INVESTMENT PRESENTATION (PHOTONZ)

    FINANCIAL MODELLING AND INVESTMENT PRESENTATION (PHOTONZ)
    Photonz has developed a business selling highly purified omega-3 derivative fatty acids as a pharmaceutical for the management of heart disease. Scarlatti prepared a business plan and financial model to present Photonz to investors and to find commercial partners for its products.

  • FINANCIAL MODELLING AND INVESTMENT PRESENTATION (NU FRUITS)

    FINANCIAL MODELLING AND INVESTMENT PRESENTATION (NU FRUITS)
    Scarlatti has had a long association with food ingredients company Nu Fruits. We have undertaken a range of project for them including detailed financial modelling for a range of new ventures under consideration. One result has been the acquisition of a food processing operation in Brazil.

  • FEASIBILITY OF A MAIZE ETHANOL BUSINESS (LANZAFUELS)

    FEASIBILITY OF A MAIZE ETHANOL BUSINESS (LANZAFUELS)
    Scarlatti contributed to the feasibility study of a bioethanol in New Zealand. Scarlatti was part of a team working to evaluate the feasibility of the maize ethanol fuel business for the New Zealand market, at a time when government policy mandated the use biofuel mix within the New Zealand fuel market (this policy has since changed). The feasibility of local production to serve that market was assessed. This was a major project conducted over an eight month period.

  • FEASIBILITY OF A BIOMASS ETHANOL BUSINESS (LANZATECH AND EECA)

    FEASIBILITY OF A BIOMASS ETHANOL BUSINESS (LANZATECH AND EECA)
    LanzaTech have developed a proprietary platform for producing lowest-cost fuel ethanol. Scarlatti developed a financial model for the application of their technology to a plant using biomass (wood) as the primary feedstock. Scarlatti helped LanzaTech to secure grant funding from EECA to partially fund the work.

  • FINANCIAL MODELLING AND INVESTMENT PRESENTATION (RIOLIFE)

    FINANCIAL MODELLING AND INVESTMENT PRESENTATION (RIOLIFE)
    Scarlatti built a financial model for this Australian health food company to project future financial information under a range of possible scenarios. This analysis was used to produce an Information Memorandum that RioLife distributed to potential investors when it was seeking a significant capital injection.

  • FINANCIAL MODEL AND BUSINESS PLAN (GENAVIA THERAPEUTICS)

    FINANCIAL MODEL AND BUSINESS PLAN (GENAVIA THERAPEUTICS)
    Genavia was a start-up bio-tech venture whose business plan featured considerable market and technical risk along with an opportunity for spectacular returns. Scarlatti developed a financial model that dealt with this uncertainty and assigned probabilities and value projections to the extensive range of potential outcomes. This allowed Genavia to communicate appropriately the potential risks and returns from its business plan to investors.